<?xml version="1.0" encoding="UTF-8"?>
<ref id="B181-marinedrugs-17-00374" class="ref">
 <label class="label">181.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Pedrosa</surname>
    <given-names class="given-names">A.C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sousa</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pinheiro-Costa</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Beato</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Falcao</surname>
    <given-names class="given-names">M.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Falcao-Reis</surname>
    <given-names class="given-names">F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Carneiro</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes</article-title>
  <source class="source">J. Ophthalmol.</source>
  <year class="year">2017</year>
  <volume class="volume">2017</volume>
  <fpage class="fpage">4263017</fpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1155/2017/4263017</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">28656102</pub-id>
 </element-citation>
</ref>
